1. Melatonin ameliorates cardiac remodelling in fructose-induced metabolic syndrome rat model by using genes encoding cardiac potassium ion channels
- Author
-
Mehmet Akif Ovali, Selma Arzu Vardar, and Ozlem Oztopuz
- Subjects
Male ,medicine.medical_specialty ,Potassium Channels ,Heart Ventricles ,Action Potentials ,Fructose ,QT interval ,Melatonin ,Rats, Sprague-Dawley ,chemistry.chemical_compound ,Insulin resistance ,Internal medicine ,Genetics ,medicine ,Animals ,Molecular Biology ,Metabolic Syndrome ,Ventricular Remodeling ,business.industry ,Heart ,General Medicine ,medicine.disease ,Potassium channel ,Rats ,Long QT Syndrome ,Endocrinology ,Blood pressure ,chemistry ,Female ,Metabolic syndrome ,business ,Dyslipidemia ,medicine.drug - Abstract
Metabolic syndrome comprises a group of disorders, including cardiac abnormalities. Ventricular arrhythmias observed in metabolic syndrome are due to the impaired ventricular repolarization. This study aims to determine the effects of melatonin on cardiac ventricular repolarization in metabolic syndrome rat model. Sprague–Dawley rats were divided into control (n = 8), melatonin (n = 8), metabolic syndrome (n = 8) and metabolic syndrome + melatonin (n = 8) groups. Fructose (200 g/lt/day) was added into the drinking water during 8 weeks of rats to induce metabolic syndrome model. In the last two weeks, melatonin (20 mg/kg/day) was administered via oral gavage. Blood pressure measurements and ECG recordings were taken at three different times. Blood and left ventricular tissue samples were harvested and the KCNQ1,3 and KCNH2 gene expressions were analysed by qRT-PCR method. We observed insulin resistance, hyperglycemia, dyslipidemia and higher systolic blood pressure in metabolic syndrome group (p
- Published
- 2021